Catalent, Inc. to Present at the UBS Global Healthcare Virtual Conference
May 21 2021 - 8:45AM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leading global provider of
advanced delivery technologies, development, and manufacturing
solutions for drugs, biologics, cell and gene therapies, and
consumer health products, today announced that members of its
executive leadership team will virtually present at the UBS Global
Healthcare Virtual Conference at 11:00 a.m. ET on May 26, 2021.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT), an S&P 500® Company, is the
leading global provider of advanced delivery technologies,
development, and manufacturing solutions for drugs, biologics, cell
and gene therapies, and consumer health products. With over 85
years serving the industry, Catalent has proven expertise in
bringing more customer products to market faster, enhancing product
performance and ensuring reliable global clinical and commercial
product supply. Catalent employs over 14,000 people, including over
2,400 scientists and technicians, at more than 40 facilities across
four continents, and in fiscal year 2020 generated over $3 billion
in annual revenue. Catalent is headquartered in Somerset, New
Jersey. For more information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210521005027/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
From Apr 2024 to May 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
From May 2023 to May 2024